Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Delmar

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Biology|July 29, 2009
Changes in transcriptome after in vivo exposure to ionising radiation reveal a highly specialised liver responseAlexandre Pawlik, Paul Delmar, Sebastien Bosse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2024
Care partner-informed meaningful change thresholds for the Clinical Dementia Rating-Sum of Boxes for trials of early Alzheimer's diseaseClaire J Lansdall, Edmond Teng, Jerome Chague, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2020
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approachMichael C Donohue, Fabian Model, Paul Delmar, et al.
Head & Neck|July 14, 2012
Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinomaFabienne Thomas, Paul Delmar, Sébastien Vergez, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Statistics in Medicine|May 16, 2018
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's diseaseGuoqiao Wang, Lei Liu, Yan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015)Tony Mok, Vera Gorbunova, Erzsebet Juhasz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 30, 2025
Japanese participant data from three gantenerumab trials in early Alzheimer's diseaseTakashi Asada, Angeliki Thanasopoulou, Paul Delmar, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Biology|July 29, 2009
Changes in transcriptome after in vivo exposure to ionising radiation reveal a highly specialised liver responseAlexandre Pawlik, Paul Delmar, Sebastien Bosse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2024
Care partner-informed meaningful change thresholds for the Clinical Dementia Rating-Sum of Boxes for trials of early Alzheimer's diseaseClaire J Lansdall, Edmond Teng, Jerome Chague, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2020
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approachMichael C Donohue, Fabian Model, Paul Delmar, et al.
Head & Neck|July 14, 2012
Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinomaFabienne Thomas, Paul Delmar, Sébastien Vergez, et al.
Pharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.
Statistics in Medicine|May 16, 2018
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's diseaseGuoqiao Wang, Scott Berry, Chengjie Xiong, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's diseaseGuoqiao Wang, Lei Liu, Yan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015)Tony Mok, Vera Gorbunova, Erzsebet Juhasz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 30, 2025
Japanese participant data from three gantenerumab trials in early Alzheimer's diseaseTakashi Asada, Angeliki Thanasopoulou, Paul Delmar, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Pageof 5